LINK: https://bswhealth.webex.com/bswhealth/j.php?MTID=m56d6ae4dee52864c95310b3da5729fbf

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Define Porto-pulmonary hypertension (2) Describe the common tests used in the diagnosis of Porto-Pulmonary hypertension (3) Describe the treatment options available in treating Porto-Pulmonary hypertension.

FACULTY DISCLOSURE: Chetan Naik, MD, is a consultant/speaker for Actelion Pharmaceuticals Company.

PLANNER DISCLOSURE: James Trotter, MD, Sumeet Asrani, MD, Gregory McKenna, MD, and Kathy Brown, RN, CCTC, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CEPTC Credit: The American Board for Transplant Certification (ABTC) has been applied for educational offering for up to 1 Category 1 Continuing Education Point for Transplant Certification (CEPTCs).

For information, please contact Karina Pena at [email protected] or call 214-820-1730